Composition
- Active ingredients
- CIPROFLOXACIN 212.6MG; CIPROFLOXACIN HYDROCHLORIDE EQ 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CIPROFLOXACIN 212.6MG; CIPROFLOXACIN HYDROCHLORIDE EQ 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseThis page
- CIPROFLOXACIN 425.2MG; CIPROFLOXACIN HYDROCHLORIDE EQ 574.9MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA021473-002 · Discontinued
- CIPROFLOXACIN 212.6MG; CIPROFLOXACIN HYDROCHLORIDE EQ 287.5MG BASE · Tablet, extended releaseNDA021554-001 · Prescription
- CIPROFLOXACIN 425.2MG; CIPROFLOXACIN HYDROCHLORIDE EQ 574.9MG BASE · Tablet, extended releaseNDA021554-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021473.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Cipro XR
- Active substance
- ciprofloxacin
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Bayer Hlthcare
- Status
- Discontinued
- FDA approval
- 13 Dec 2002
- Application
- NDA021473-001